Ivermectin: 25 years and still going strong

International Journal of Antimicrobial Agents

Volumn 31, Issue 2, 2008, Pages 91-98

  Omura S ^a  

^a KITASATO INSTITUTE   (Japan)

Author keywords

Anthelmintic; Ivermectin; Lymphatic filariasis; Onchocerciasis; Public private partnerships

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; IVERMECTIN; TIABENDAZOLE;

AFRICA; ASCARIS LUMBRICOIDES; BRUGIA MALAYI; CENTRAL AMERICA; DRUG SAFETY; DRUG SYNTHESIS; ENTEROBIUS; HUMAN; LIVESTOCK; LOA LOA; MANZONELLA OZZARDI; NEMATODE; NONHUMAN; ONCHOCERCIASIS; PET ANIMAL; PRIORITY JOURNAL; PRODUCTIVITY; SHORT SURVEY; SOUTH AMERICA; STREPTOMYCES; STREPTOMYCES AVERMITILIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TRICHURIS; UNSPECIFIED SIDE EFFECT; WUCHERERIA BANCROFTI;

ANIMALS; ANTIPARASITIC AGENTS; FILARICIDES; HUMANS; IVERMECTIN; ONCHOCERCIASIS;

EID: 37549071056     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.08.023     Document Type: Short Survey

References (42)

1. Õmura S., and Crump A. Life and times of ivermectin: a success story. Nat Rev Microbiol 2 (2004) 984-989
2. Stapley EO, Woodruff HB. Avermectins, antiparasitic lactones produced by Streptomyces avermitilis isolated from a soil in Japan. Proceedings of an International Conference on Trends in Antibiotic Research: Genetics, Biosyntheses, Actions and New substances. Tokyo: Japan Antibiotics Research Association; 1982. pp. 154-70.
3. Burg R.W., and Stapley E.O. Isolation and characterization of the producing organism. In: Campbell W.C. (Ed). Ivermectin and abamectin (1989), Springer, New York pp. 24-32
4. Burg R.W., Miller B.M., Baker E.E., et al. Avermectins, new family of potent anthelmintic agents: producing organisms and fermentation. Antimicrob Agents Chemother 15 (1979) 361-367
5. Miller T.W., Chaiet L., Cole D.J., et al. Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties. Antimicrob Agents Chemother 15 (1979) 368-371
6. Egerton J.R., Ostlind D.A., Blair L.S., et al. Avermectins, new family of potent anthelmintic agents: efficacy of the B1A component. Antimicrob Agents Chemother 15 (1979) 372-378
7. Chabala J.C., Mrozik M., Tolman R.L., et al. Ivermectin, a new broad spectrum antiparasitic agent. J Med Chem 23 (1980) 1134-1136
8. Campbell W.C., Fisher M.H., Stapley E.O., et al. A potent new antiparasitic agent. Science 221 (1983) 823-828
9. Arena J.P., Liu K.K., Paress P.S., et al. Expression of a glutamate-activated chloride current in Xenopus oocytes injected with Caenorhabditis elegans RNA: Evidence for modulation by avermectin. Brain Res 15 (1992) 339-348
10. Omura S. Mode of action of avermectin. In: Omura S. (Ed). Macrolide antibiotics: chemistry, iology and practice (2002), Academic Press, New York pp. 571-6
11. Schoop W., and Soll M. Ivermectin, abamectin and eprinomectin. Macrocyclic lactones in antiparasitic therapy (2002), CABI Publishing, New York pp. 1-29
12. Iekeda H., and Omura S. Avermectin biosynthesis. Chem Rev 97 (1997) 2591-2609
13. Omura S., Ikeda H., Ishikawa J., et al. Genome sequence of an industrial microorganism Streptomyces avermitilis: Deducing the ability of producing secondary metabolites. Proc Nat Acad Sci (USA) 98 (2001) 12215-12220
14. Ikeda H., Ishikawa J., Hanamoto A., et al. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nature Biotechnol 21 (2003) 526-531
15. Ikeda H, Omura S. Unpublished data, 2007.
16. Aziz M.A., Diallo S., Diop I.M., et al. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 2 (1982) 171-173
17. Thylefors B. Eliminating onchocerciasis as a public health problem. Trop Med Int Health 9 (2004) A1-A3
18. Frost L., Reich M., Fujisaki T., et al. A partnership for ivermectin: social worlds and boundary objects. Public-private partnerships for public health (2002), Harvard University Press, Boston, MA pp. 87-114
19. Mectizan Donation Programme. Annual highlights. The accomplishments of the Mectizan Donation Program in its 19th year. GA: Mectizan Donation Program; 2007.
20. Gaillard J, Hassan M, Wasst R, et al. Africa. In: UNESCO Science Report, 2005. Paris, France: UNESCO; 2005. pp. 177-201.
21. Diallo S., Aziz M.A., Lariviere M., et al. A double-blind comparison of the efficacy and safety of ivermectin and diethycarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Trans Roy Soc Trop Med Hyg 80 (1986) 927-934
22. Addis D.G., Beach M.J., Streit T.G., et al. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 350 (1997) 480-484
23. Ismail M.M., Jayakody R.L., Weil G.J., et al. Efficacy of single dose combinations of albendazole, ivermectin and diethycarbamazine for the treatment of bancroftian filariasis. Trans Roy Soc Trop Med Hyg 92 (1997) 94-97
24. In: Murray P.R., Baron E.J., Jorgensen J.H., et al. (Eds). Manual of clinical microbiology (2003), ASM Press, Washington DC pp. 2113
25. Zaha O., Hirata T., Kinjo F., et al. In: Omura S. (Ed). Ivermectin in clinical practice. Macrolide antibiotics chemistry, biology, and practice (2002), Academic Press, San Diego, CA pp. 403-19
26. Naquira C., Jimenez G., Guerra J.G., et al. Ivermectin for human strongylodiasis and other intestinal helminthes. Am J Trop Med Hyg 40 (1989) 304-309
27. Freedman D.O., Zierdt W.S., Lujan A., et al. The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans. J Infect Dis 159 (1989) 151-153
28. Glaziou P., Cartel J.L., Alzieu P., et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 44 (1993) 331-332
29. Macoleta-Ruiz E., and Pena-Gonzalez G. The treatment of scabies with oral ivermectin. Gac Med Mex 129 (1993) 201-205
30. Zaha O., Hirata T., Kinjo F., et al. Strongyloidiasis: Progress in diagnosis and treatment. Intern Med 39 (2000) 695-700
31. WHO. Water-related diseases: Scabies (http://www.who.int/water_sanitation_health/diseases/scabies/en/) accessed 24/5/07.
32. Hennesy DR, Alvinerie MR. Pharmacokinetics of the macrocyclic lactones: Conventional wisdom and new paradigms. Macrocyclic lactones in antiparasite therapy. New York: CABI Publishing; 2002. pp. 97-124.
33. Halley B.A., Theodore A.J., Anthony Y.H., et al. The environmental impact of the use of ivermectin: environmental effects and fate. Chemosphere 18 (1989) 1543-1563
34. Wall R.A., and Strong L. Environmental consequences of treating cattle with the antiparasitic drug ivermectin. Nature 327 (1987) 418-421
35. Palmer R.H., Rodger H., Drinan E., et al. Preliminary trials on the efficacy of ivermectin against parasitic copepods of Atlantic salmon. Bull Euro Assoc Fish Pathol 7 (1987) 47-54
36. Davies I.M., and Rodger G.K. A review of the use of ivermectin as a treatment for sea lice Lepeophtheirus salmonis and Caligus elongatus infestation in farmed Atlantic salmon (Salmo salar). Aquaculture Res 31 (2000) 869-883
37. Kövecses J, Marcogliese DJ. Avermectins: Potential environmental risks and impacts on freshwater ecosystems in Quebec. Scieintific and technical report ST-233E. Environment Canada-Quebec region, Environmental Conservation, St Lawrence Centre 2005. pp. 72.
38. Chippaux J.P., Boussinesq M., Gardon J., et al. Severe adverse reaction risk during mass treatment with ivermectin in loiasis-endemic areas. Parasitology Today 2 (1996) 448-450
39. Õmura S., Miyadera H., Ui H., et al. An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria. Proc Natl Acad Sci (USA) 98 (2001) 60-62
40. Langworthy S., Renz A., Mackenstedt U., et al. Macrofilaricidal activity of tetracycline against the filarial nematode, Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc R Soc London B Biol 267 (2000) 1063-1069
41. ® (ivermectin) in the treatment of human onchocerciasis. Acta Tropica 84 (2002) 49-53
42. Awadzi K. Clinical picture and outcome of serious adverse events in the treatment of onchocerciasis. Filaria J 2 Suppl. 1 (2003) S1-S9